New therapeutic strategies were spotlighted at #AACR26, with first-time presentations of the structures and mechanisms behind four novel molecules—EO-811, AZD8359, TNG961, and EPI-326. Learn more in AACR Annual Meeting News: https://t.co/8VeCFe4hwn https://t.co/DzcYH5vgO7